With close ties to MIT, Digital Cognition Technologies Inc (DCT) has developed a highly sensitive test available for objective, reliable, and quantified measurement of cognitive function. Developed at MIT and Leahey Hospital & Medical Center over the past decade, CCT is using artificial intelligence technology and clinical expertise with normative data from the Framingham Heart Study to unlock robust measures of brain function from natural drawing behavior. Potential uses are to screen for cognitive impairment, monitor cognitive health over time, and track change in cognitive function in response to treatment. Provides useful results very quickly, he technique is non-invasive, inexpensive, requires equipment that is small in desktop space required, and takes only minutes to perform.
